Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.34203.06-34.5980.29-16.93

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 9.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.34
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2025 9.34
-95.40
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹897.3 Cr 9.9% 2.8% 15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,751.0 Cr 0.2% 7.1% -7.7% Stock Analytics
DIVIS LABORATORIES ₹176,634.0 Cr 1% 16.8% 12.7% Stock Analytics
CIPLA ₹124,437.0 Cr -2.7% 3.5% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,871.0 Cr 0.6% 0.4% 4.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,333.0 Cr -6.4% -2.7% -3.9% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

9.9%

2.8%

15.1%

SENSEX

-0.2%

5%

5.4%


You may also like the below Video Courses